Showing results (481-490 of 532) with videos related to
Sort By:
Pageof 54
Circulation. Cardiovascular Interventions|September 17, 2017
White Blood Cell Count and Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention in the Contemporary Era: Insights From the PARIS Study (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients Registry)Binita Shah, Usman Baber, Stuart J Pocock, et al.Circulation|November 11, 2020
Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced TrialStefan D Anker, Javed Butler, Gerasimos Filippatos, et al.European Journal of Heart Failure|June 26, 2024
Incremental value of C-reactive protein to the MEESSI acute heart failure risk scoreDesiree Wussler, Maria Belkin, Samyut Shrestha, et al.Translational Stroke Research|July 29, 2017
Infections Up to 76 Days After Stroke Increase Disability and DeathAnnastazia E Learoyd, Lisa Woodhouse, Laurence Shaw, et al.Journal of the American College of Cardiology|October 2, 2020
Implications of Alternative Definitions of Peri-Procedural Myocardial Infarction After Coronary RevascularizationJohn Gregson, Gregg W Stone, Ori Ben-Yehuda, et al.Circulation. Cardiovascular Interventions|June 6, 2018
Incidence, Patterns, and Impact of Dual Antiplatelet Therapy Cessation Among Patients With and Without Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention: Results From the PARIS Registry (Patterns of Non-Adherence to Anti-Platelet Regimens in Stented Patients)Usman Baber, Shawn X Li, Rebecca Pinnelas, et al.Lancet (London, England)|December 25, 2017
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trialPhilip M Bath, Lisa J Woodhouse, Jason P Appleton, et al.Journal of the American College of Cardiology|November 4, 2016
2-Year Outcomes of High Bleeding Risk Patients After Polymer-Free Drug-Coated StentsPhilippe Garot, Marie-Claude Morice, Damras Tresukosol, et al.The New England Journal of Medicine|November 25, 2006
Bivalirudin for patients with acute coronary syndromesGregg W Stone, Brent T McLaurin, David A Cox, et al.Annals of Internal Medicine|January 29, 2019
External Validation of the MEESSI Acute Heart Failure Risk Score: A Cohort StudyDesiree Wussler, Nikola Kozhuharov, Zaid Sabti, et al.Pageof 54